|
NSL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.621160E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.18079999999965E-05 |
| Normal-vs-Stage2 |
2.249600E-02 |
| Normal-vs-Stage3 |
3.970800E-01 |
| Normal-vs-Stage4 |
7.392200E-01 |
| Stage1-vs-Stage2 |
6.819400E-01 |
| Stage1-vs-Stage3 |
2.135900E-02 |
| Stage1-vs-Stage4 |
3.034000E-04 |
| Stage2-vs-Stage3 |
9.289500E-02 |
| Stage2-vs-Stage4 |
1.873530E-02 |
| Stage3-vs-Stage4 |
3.083400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.638900E-04 |
| Normal-vs-AfricanAmerican |
3.481400E-01 |
| Normal-vs-Asian |
3.593800E-01 |
| Caucasian-vs-AfricanAmerican |
1.622630E-03 |
| Caucasian-vs-Asian |
9.441200E-01 |
| AfricanAmerican-vs-Asian |
1.856840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339580E-02 |
| Normal-vs-Female |
1.821120E-03 |
| Male-vs-Female |
2.721800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.048600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.716400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.180000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.240000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.591400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.814800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.786000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.417800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.926800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.917600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.36729999999463E-05 |
| Normal-vs-Grade 2 |
1.68808999999603E-05 |
| Normal-vs-Grade 3 |
3.123600E-02 |
| Normal-vs-Grade 4 |
7.764300E-02 |
| Grade 1-vs-Grade 2 |
1.622390E-01 |
| Grade 1-vs-Grade 3 |
8.296600E-03 |
| Grade 1-vs-Grade 4 |
3.990300E-04 |
| Grade 2-vs-Grade 3 |
1.795750E-02 |
| Grade 2-vs-Grade 4 |
4.09209999996385E-07 |
| Grade 3-vs-Grade 4 |
1.320500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.19164744317413E-12 |
| Normal-vs-ccB subtype |
7.233000E-01 |
| ccA subtype-vs-ccB subtype |
1.07590047981887E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.299900E-03 |
| Normal-vs-N1 |
6.928000E-01 |
| N0-vs-N1 |
6.116000E-01 |
|
|
